List of works - Olivier Cheneval

Accurate de novo design of hyperstable constrained peptides

scientific article

Corrigendum to "Spider peptide toxin HwTx-IV engineered to bind to lipid membranes has an increased inhibitory potency at human voltage-gated sodium channel hNaV1.7" [Biochim. Biophys. Acta 1859(5) (2017) 835-844].

scientific article

Defense Peptides Engineered from Human Platelet Factor 4 Kill Plasmodium by Selective Membrane Disruption

scientific article published on 19 July 2018

Design and synthesis of truncated EGF-A peptides that restore LDL-R recycling in the presence of PCSK9 in vitro

scientific article

Design of a cyclotide antagonist of neuropilin-1 and -2 that potently inhibits endothelial cell migration.

scientific article

Development of Novel Melanocortin Receptor Agonists Based on the Cyclic Peptide Framework of Sunflower Trypsin Inhibitor-1.

scientific article published on 31 March 2018

Development of cell-penetrating peptide-based drug leads to inhibit MDMX:p53 and MDM2:p53 interactions

scientific article published on 10 June 2016

Efficient enzymatic cyclization of an inhibitory cystine knot-containing peptide

scientific article

Fmoc-based synthesis of disulfide-rich cyclic peptides

scientific article published on 11 June 2014

Interaction of Tarantula Venom Peptide ProTx-II with Lipid Membranes Is a Prerequisite for Its Inhibition of Human Voltage-gated Sodium Channel NaV1.7.

scientific article published on 16 June 2016

Mass spectrometry strategies for venom mapping and peptide sequencing from crude venoms: case applications with single arthropod specimen

scientific article published on 19 April 2006

Molecular characterisation of endogenous snake venom metalloproteinase inhibitors

scientific article published on 20 November 2007

Optimization of the cyclotide framework to improve cell penetration properties

scientific article

Orientation and Location of the Cyclotide Kalata B1 in Lipid Bilayers Revealed by Solid-State NMR.

scientific article

Peptide-Membrane Interactions Affect the Inhibitory Potency and Selectivity of Spider Toxins ProTx-II and GpTx-1

scientific article published on 21 December 2018

Plant-derived decapeptide OSIP108 interferes with Candida albicans biofilm formation without affecting cell viability

scientific article

Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties

scientific article published on 25 July 2017

Spider peptide toxin HwTx-IV engineered to bind to lipid membranes has an increased inhibitory potency at human voltage-gated sodium channel hNaV1.7.

scientific article published on 20 January 2017

Structure-activity relationship study of the plant-derived decapeptide OSIP108 inhibiting Candida albicans biofilm formation.

scientific article

Targeted Delivery of Cyclotides via Conjugation to a Nanobody

scientific article published on 05 October 2018

The plant decapeptide OSIP108 can alleviate mitochondrial dysfunction induced by cisplatin in human cells.

scientific article published on 19 September 2014

The venom of the snake genus Atheris contains a new class of peptides with clusters of histidine and glycine residues

scientific article published in January 2007

Using the MCoTI-II Cyclotide Scaffold To Design a Stable Cyclic Peptide Antagonist of SET, a Protein Overexpressed in Human Cancer

scientific article published on 21 December 2015

List of works by Olivier Cheneval

Accurate de novo design of hyperstable constrained peptides

Corrigendum to "Spider peptide toxin HwTx-IV engineered to bind to lipid membranes has an increased inhibitory potency at human voltage-gated sodium channel hNaV1.7" [Biochim. Biophys. Acta 1859(5) (2017) 835-844].

Defense Peptides Engineered from Human Platelet Factor 4 Kill Plasmodium by Selective Membrane Disruption

Design and synthesis of truncated EGF-A peptides that restore LDL-R recycling in the presence of PCSK9 in vitro

Design of a cyclotide antagonist of neuropilin-1 and -2 that potently inhibits endothelial cell migration.

Development of Novel Melanocortin Receptor Agonists Based on the Cyclic Peptide Framework of Sunflower Trypsin Inhibitor-1.

Development of cell-penetrating peptide-based drug leads to inhibit MDMX:p53 and MDM2:p53 interactions

Efficient enzymatic cyclization of an inhibitory cystine knot-containing peptide

Fmoc-based synthesis of disulfide-rich cyclic peptides

Interaction of Tarantula Venom Peptide ProTx-II with Lipid Membranes Is a Prerequisite for Its Inhibition of Human Voltage-gated Sodium Channel NaV1.7.

Mass spectrometry strategies for venom mapping and peptide sequencing from crude venoms: case applications with single arthropod specimen

Molecular characterisation of endogenous snake venom metalloproteinase inhibitors

Optimization of the cyclotide framework to improve cell penetration properties

Orientation and Location of the Cyclotide Kalata B1 in Lipid Bilayers Revealed by Solid-State NMR.

Peptide-Membrane Interactions Affect the Inhibitory Potency and Selectivity of Spider Toxins ProTx-II and GpTx-1

Plant-derived decapeptide OSIP108 interferes with Candida albicans biofilm formation without affecting cell viability

Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties

Spider peptide toxin HwTx-IV engineered to bind to lipid membranes has an increased inhibitory potency at human voltage-gated sodium channel hNaV1.7.

Structure-activity relationship study of the plant-derived decapeptide OSIP108 inhibiting Candida albicans biofilm formation.

Targeted Delivery of Cyclotides via Conjugation to a Nanobody

The plant decapeptide OSIP108 can alleviate mitochondrial dysfunction induced by cisplatin in human cells.

The venom of the snake genus Atheris contains a new class of peptides with clusters of histidine and glycine residues

Using the MCoTI-II Cyclotide Scaffold To Design a Stable Cyclic Peptide Antagonist of SET, a Protein Overexpressed in Human Cancer